NCCN Flash Updates: NCCN Guidelines

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for B-Cell Lymphomas. These NCCN Guidelines^® are currently available as Version 2.2022.

Link directly to the Updates section of the NCCN Guidelines: B-Cell Lymphomas

FOLL-B 2 of 5 and BCEL-C 2 of 6

• Footnote n added: Brentuximab vedotin and ibrutinib are not options for second-line therapy for follicular lymphoma.

Previous updates to the NCCN Guidelines for B-Cell Lymphomas can be found in the UPDATES section of the current version.